REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $586,000,000 | – | 83,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 527,000 | $4,653,000 | 2.58% |
| 683 Capital Management, LLC | 3,631,019 | $32,062,000 | 2.08% |
| CVI Holdings, LLC | 22,367 | $198,000 | 0.33% |
| MENTA CAPITAL LLC | 85,785 | $757,000 | 0.26% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $3,717,000 | 0.10% |
| Kepos Capital LP | 218,800 | $1,932,000 | 0.10% |
| Claret Asset Management Corp | 47,522 | $420,000 | 0.08% |
| Migdal Insurance & Financial Holdings Ltd. | 389,914 | $3,443,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 38,806 | $323,000 | 0.06% |
| Orbimed Advisors | 284,900 | $2,516,000 | 0.03% |